Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer.

Beryl L Manning-GeistMackenzie W SullivanVishnudas SardaAllison A GockleyMarcela G Del CarmenUrsula MatulonisWhitfield B GrowdonNeil S HorowitzRoss S BerkowitzRachel M ClarkMichael J Worley

Published in: Annals of surgical oncology (2021)

Adjuvant IV/IP chemotherapy was associated with oncologic benefit in miliary disease spread. This survival benefit was not observed in nonmiliary disease.

Keyphrases

locally advanced
early stage
prostate cancer
squamous cell carcinoma
rectal cancer
radical prostatectomy